Navigation Links
Dr. Peter C. Neligan, Author of 3rd Edition of Elsevier's Plastic Surgery Text, Available for Comment on the Contributions of Dr. Joseph Murray
Date:11/27/2012

PHILADELPHIA, Nov. 27, 2012 /PRNewswire/ -- In the wake of the passing of Nobel Prize winning surgeon Dr. Joseph Murray, who carried out the first successful kidney transplant in 1954, Dr. Peter C. Neligan, author of the definitive textbook of the discipline, Plastic Surgery, (3rd Ed., Elsevier, October 2012) is available to comment on Dr. Murray's legacy of innovation. Dr. Murray died on Monday in Boston at the age of 93.

"The history of Plastic Surgery is one of innovation in medicine, and Dr. Murray's contributions paved the way for developments that today continue in areas such as hand and face transplantation," says Dr. Neligan, author of five books, more than 50 book chapters and 170 peer-reviewed papers.

A professor of Plastic Surgery and Otolaryngology/Neck Surgery at the University of Washington Medical Center in Seattle, Dr. Neligan spent four years editing Plastic Surgery, working with the Elsevier team and with the volume editors. The 6-volume text is the first update in a decade, and includes 160 videos and online resources that bring the latest techniques to the practitioner's iPad or cell phone.

"Many people think of plastic surgery as a cosmetic practice, but Aesthetic Surgery fills only one of the six volumes in the Plastic Surgery text," Dr. Neligan says. "Plastic Surgeons are leading the way with new developments in stem cell therapy, tissue engineering, and inductive therapies; aesthetic surgical techniques and nonsurgical treatments; conjoined twin separation and other craniofacial surgery advances; microsurgical lymphatic reconstruction, super microsurgery, nerve transfers in hand surgery, functional prosthetics, and more."

Additional information about Dr. Neligan and Plastic Surgery is available at http://elsevierauthors.com/peterneligan.



'/>"/>
SOURCE Elsevier, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Elsevier / MEDai Names Dr. Peter Edelstein as Chief Medical Officer and Dr. Gerald Osband as Director of Product Strategy
2. Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors
3. Kansas Bioscience Authority Announces FY11 Outcomes of $207 Million
4. Quest Diagnostics STRATIFY JCV™ First FDA Market Authorized Antibody-based Blood Test to Help Stratify PML Risk in Multiple Sclerosis Patients
5. Swiss, EMA, US Pharmacopoeia and World Health Organization Authorities to Provide an Update on Cool Chain Regulations
6. Auditors Complete Kansas Bioscience Authority Forensic Audits
7. Dietary Supplements Extensively Regulated, Say Authors of New Article
8. Fitzsimons Redevelopment Authority Names New President & CEO
9. UBM Canon, the Global MedTech Authority, and the Medical Design Excellence Awards Announce Dean Kamen as the Presenter of the 2012 Lifetime Achievement Award
10. Immunomic Therapeutics Receives IND Authorization for Phase I Study of JRC-LAMP-Vax Vaccine to Treat Japanese Red Cedar (Sugi) Allergy
11. MD+DI, the Global MedTech Industry Authority, Wins a 2012 Maggie for Best Cover in the Medical, Dental & Related Services/Trade Category
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... HAMILTON, Bermuda , Feb. 27, ... ADXS ) and SELLAS Life Sciences ... developing cancer immunotherapies, today announced that Advaxis has ... cancer immunotherapy agent using Advaxis, proprietary Lm ... targeted heteroclitic peptide antigen mixture (galinpepimut-S). ...
(Date:2/25/2017)... ... February 25, 2017 , ... The STARR Coalition ... effort to create meaningful change by increasing communication, partnerships and goodwill among stakeholders ... and patients’ mental health well-being. , Both organizations are dedicated to promoting patient ...
(Date:2/24/2017)... , Feb. 24, 2017  Aethlon Medical, Inc. (Nasdaq: ... authored by its Chairman and CEO, Jim Joyce ... Munich Security Conference last Saturday, Bill Gates ... kill more people than nuclear weapons. Mr. Gates expressed ... U.K. intelligence agencies, that scientific terrorists have access to ...
(Date:2/24/2017)... China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the ... today announced its financial results for the fourth quarter and ... Financial Highlights Total sales in the ... or increased by 13.6% in USD terms to $77.6 million ... Gross profit increased by 13.3% to $46.8 million ...
Breaking Biology Technology:
(Date:2/13/2017)... 13, 2017 Former 9/11 Commission border counsel ... Janice Kephart of Identity Strategy Partners, LLP, ... Trump,s "Executive Order: Protecting the Nation From Foreign ... "As President Trump,s ,Travel Ban, Executive Order ... essentially banned the travel ban, it is important that ...
(Date:2/8/2017)... 7, 2017  Aware, Inc. (NASDAQ: AWRE ), ... financial results for its quarter and year ended December 31, ... 2016 was $3.9 million compared to $6.9 million in the ... of 2016 was $0.6 million compared to $2.6 million in ... quarter of 2016 was $0.5 million, or $0.02 per diluted ...
(Date:2/7/2017)... Feb. 7, 2017   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... its innovative, highly flexible and award winning eClinical solution, ... iMedNet is a proven Software-as-a-Service (SaaS) clinical ... Capture (EDC), but also delivers an entire suite of ...
Breaking Biology News(10 mins):